Based on the PPI network and KEGG pathway analyses, we selected relevant targets, namely IL-6, CYCS, TGFB1, IL1B, SOCS3, and CEPBA, enriched in the NAFLD pathway for molecular docking. Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.